IGF1, insulin like growth factor 1, 3479

N. diseases: 1206; N. variants: 36
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038868
Disease: Progressive supranuclear palsy
Progressive supranuclear palsy
0.010 AlteredExpression disease BEFREE Serum IGF-1 levels (mean ± standard error) were not significantly different among the patients with different neurodegenerative diseases: Parkinson's disease (PD; n = 73), 112.1 ± 5.1 ng/mL; progressive supranuclear palsy (n = 15), 102.9 ± 8.3 ng/mL; multiple system atrophy (n = 22), 103.1 ± 37.6 ng/mL; Alzheimer's disease (AD; n = 18), 102.2 ± 9.4 ng/mL; amyotrophic lateral sclerosis (n = 6), 105.5 ± 27.4 ng/mL; dementia with Lewy bodies (n = 14), 82.4 ± 7.4 ng/mL; frontotemporal dementia (n = 6), 90.0 ± 17.0 ng/mL; and corticobasal syndrome (n = 2), 118.0 ± 14.0 ng/mL. 30903695 2019
CUI: C0039093
Disease: Congenital abnormal Synostosis
Congenital abnormal Synostosis
0.010 AlteredExpression disease BEFREE Compound heterozygous mice with selective disinhibition of RUNX2 and either overexpression of IGF1 or loss of function of GSK3β demonstrated an increase in the frequency and severity of synostosis as compared to mice with the RUNX2 disinhibition alone. 31442251 2019
Hereditary hemorrhagic telangiectasia
0.010 AlteredExpression disease BEFREE Our research successfully identified miRNA dysregulation and elevated IGF1 mRNA levels in PBMCs from HHT patients. 30512964 2019
CUI: C0040028
Disease: Thrombocythemia, Essential
Thrombocythemia, Essential
0.010 Biomarker disease BEFREE We suggest that adding quantification of IGF-1R in blood MNC by flow cytometry is useful in differentiating ET from RT. 31479555 2019
CUI: C0085612
Disease: Ventricular arrhythmia
Ventricular arrhythmia
0.010 AlteredExpression disease BEFREE Both HGF and IGF-1 enhanced the expression of Cx43 and improved induced ventricular arrhythmia in rats with MI. 31555539 2019
CUI: C0151313
Disease: Sensory neuropathy
Sensory neuropathy
0.010 AlteredExpression disease BEFREE This is the first demonstration that sensory neuropathy affects cardiac miRNA expression network targeting <i>IGF-1</i>, <i>SLC2a-12</i>, <i>EIF-4e</i>, and <i>ULK-2</i>, which may contribute to cardiac diastolic dysfunction. 30823517 2019
CUI: C0151650
Disease: Renal fibrosis
Renal fibrosis
0.010 AlteredExpression disease BEFREE Moreover, renal fibrosis in DKD (without treatment) was associated with Snail1 overexpression that was effectively prevented by IGF-1R inhibition. 31361542 2019
CUI: C0151936
Disease: Disorder of tendon
Disorder of tendon
0.010 Biomarker group BEFREE These studies indicate that IGF1 signaling is required for proper postnatal tendon growth and support the potential use of IGF1 in the treatment of tendon disorders.-Disser, N. P., Sugg, K. B., Talarek, J. R., Sarver, D. C., Rourke, B. J., Mendias, C. L. Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth. 31536390 2019
CUI: C0152459
Disease: Linear atrophy
Linear atrophy
0.010 AlteredExpression disease BEFREE These results were consistent with qPCR experiments that displayed high levels of IGF-1R in the stria vascularis (SV) of both E and P animal groups compared to combination treatment (E + P) animals. 30845368 2019
CUI: C0205969
Disease: Thymic Carcinoma
Thymic Carcinoma
0.010 AlteredExpression disease BEFREE In IHC results, SOX2 (HR: 7.57, P = 0.001) and IGF-1 (HR: 9.43, P = 0.001) expression levels in TC were significantly higher than those in TM. 31097100 2019
CUI: C0220597
Disease: Adult Hodgkin Lymphoma
Adult Hodgkin Lymphoma
0.010 AlteredExpression disease BEFREE The activity of IGF-MTX in Hodgkin lymphoma should be explored. 31633515 2019
CUI: C0220644
Disease: Childhood Hodgkin Lymphoma
Childhood Hodgkin Lymphoma
0.010 AlteredExpression disease BEFREE The activity of IGF-MTX in Hodgkin lymphoma should be explored. 31633515 2019
Pituitary-dependent Cushing's disease
0.010 Biomarker disease BEFREE Patients with untreated Cushing's disease may have elevated IGF-1, which decreases following remission. 30901100 2019
CUI: C0231528
Disease: Myalgia
Myalgia
0.010 Biomarker phenotype BEFREE Blood lactate, serum concentrations of growth hormone (GH), testosterone, insulin-like growth factor 1 (IGF-1) and cortisol, MVC strength, and SOR were measured before and after each exercise. 31356513 2019
CUI: C0236642
Disease: Pick Disease of the Brain
Pick Disease of the Brain
0.010 AlteredExpression disease BEFREE Serum IGF-1 levels (mean ± standard error) were not significantly different among the patients with different neurodegenerative diseases: Parkinson's disease (PD; n = 73), 112.1 ± 5.1 ng/mL; progressive supranuclear palsy (n = 15), 102.9 ± 8.3 ng/mL; multiple system atrophy (n = 22), 103.1 ± 37.6 ng/mL; Alzheimer's disease (AD; n = 18), 102.2 ± 9.4 ng/mL; amyotrophic lateral sclerosis (n = 6), 105.5 ± 27.4 ng/mL; dementia with Lewy bodies (n = 14), 82.4 ± 7.4 ng/mL; frontotemporal dementia (n = 6), 90.0 ± 17.0 ng/mL; and corticobasal syndrome (n = 2), 118.0 ± 14.0 ng/mL. 30903695 2019
CUI: C0264716
Disease: Chronic heart failure
Chronic heart failure
0.010 Biomarker disease BEFREE Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure. 31359246 2019
CUI: C0265372
Disease: Fetal hydantoin syndrome
Fetal hydantoin syndrome
0.010 Biomarker disease BEFREE We observed a laboratory profile compatible with IGF-1 insensitivity in some patients with FHS. 31715605 2019
CUI: C0276447
Disease: Rhinovirus infection
Rhinovirus infection
0.010 Biomarker disease BEFREE Then, purified DsbA-IGF1 was cleaved by human rhinovirus 3C protease, and authentic IGF1 was obtained in flow through of a subtractive IMAC. 30868206 2019
CUI: C0280324
Disease: Laryngeal Squamous Cell Carcinoma
Laryngeal Squamous Cell Carcinoma
0.010 Biomarker disease BEFREE We compared IGF-1R and EGFR immunohistochemical scores in patients with LSCC achieving long-term remission post-radiotherapy (n = 23), patients treated with primary laryngectomy (n = 22) or salvage laryngectomy following radiotherapy recurrence (n = 18). 31536667 2019
CUI: C0281899
Disease: Prolapsed lumbar disc
Prolapsed lumbar disc
0.010 Biomarker disease BEFREE BACKGROUND The expression and mechanism of IL-1, IL-2, IL-8, BMP, FGF1, and IGF-1 in Sprague-Dawley (SD) rats with lumbar disc herniation were investigated. 30716059 2019
CUI: C0282666
Disease: Very Low Birth Weight
Very Low Birth Weight
0.010 AlteredExpression phenotype BEFREE Reduced environmental stimuli is associated with improved insulin-like growth factor-1 levels and physical growth in very low birth weight premature infants. 31086596 2019
CUI: C0302885
Disease: Testicular dysgenesis
Testicular dysgenesis
0.010 Biomarker disease BEFREE The GC-IGF1 axis-mediated testicular dysplasia caused by prenatal caffeine exposure. 31141788 2019
CUI: C0338451
Disease: Frontotemporal dementia
Frontotemporal dementia
0.010 AlteredExpression disease BEFREE Serum IGF-1 levels (mean ± standard error) were not significantly different among the patients with different neurodegenerative diseases: Parkinson's disease (PD; n = 73), 112.1 ± 5.1 ng/mL; progressive supranuclear palsy (n = 15), 102.9 ± 8.3 ng/mL; multiple system atrophy (n = 22), 103.1 ± 37.6 ng/mL; Alzheimer's disease (AD; n = 18), 102.2 ± 9.4 ng/mL; amyotrophic lateral sclerosis (n = 6), 105.5 ± 27.4 ng/mL; dementia with Lewy bodies (n = 14), 82.4 ± 7.4 ng/mL; frontotemporal dementia (n = 6), 90.0 ± 17.0 ng/mL; and corticobasal syndrome (n = 2), 118.0 ± 14.0 ng/mL. 30903695 2019
CUI: C0338831
Disease: Manic
Manic
0.010 AlteredExpression disease BEFREE Serum levels of IGF-1 were higher in acute manic episodes and in remission after mania than in lithium-treated patients. 30336492 2019
Mixed anxiety and depressive disorder
0.010 GeneticVariation disease BEFREE Then, we analyzed associations of IGF-1 variants with neuropsychiatric symptoms after mTBI, including anxiety, depression, dizziness, and sleep disturbances. 31787098 2019